Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?

• Discuss ASCCP guideline. • CIN3 reliable surrogates for cervical cancer? • The Pittsburgh Cervical Cancer Screening Model.

Detalles Bibliográficos
Autores principales: Austin, R. Marshall, Onisko, Agnieszka, Zhao, Chengquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Cytopathology. Published by Elsevier Inc. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387921/
https://www.ncbi.nlm.nih.gov/pubmed/32839150
http://dx.doi.org/10.1016/j.jasc.2020.07.133
_version_ 1783564215462658048
author Austin, R. Marshall
Onisko, Agnieszka
Zhao, Chengquan
author_facet Austin, R. Marshall
Onisko, Agnieszka
Zhao, Chengquan
author_sort Austin, R. Marshall
collection PubMed
description • Discuss ASCCP guideline. • CIN3 reliable surrogates for cervical cancer? • The Pittsburgh Cervical Cancer Screening Model.
format Online
Article
Text
id pubmed-7387921
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society of Cytopathology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-73879212020-07-29 Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk? Austin, R. Marshall Onisko, Agnieszka Zhao, Chengquan J Am Soc Cytopathol Commentary • Discuss ASCCP guideline. • CIN3 reliable surrogates for cervical cancer? • The Pittsburgh Cervical Cancer Screening Model. American Society of Cytopathology. Published by Elsevier Inc. 2020 2020-07-29 /pmc/articles/PMC7387921/ /pubmed/32839150 http://dx.doi.org/10.1016/j.jasc.2020.07.133 Text en © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Austin, R. Marshall
Onisko, Agnieszka
Zhao, Chengquan
Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
title Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
title_full Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
title_fullStr Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
title_full_unstemmed Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
title_short Are CIN3 risk or CIN3+ risk measures reliable surrogates for invasive cervical cancer risk?
title_sort are cin3 risk or cin3+ risk measures reliable surrogates for invasive cervical cancer risk?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387921/
https://www.ncbi.nlm.nih.gov/pubmed/32839150
http://dx.doi.org/10.1016/j.jasc.2020.07.133
work_keys_str_mv AT austinrmarshall arecin3riskorcin3riskmeasuresreliablesurrogatesforinvasivecervicalcancerrisk
AT oniskoagnieszka arecin3riskorcin3riskmeasuresreliablesurrogatesforinvasivecervicalcancerrisk
AT zhaochengquan arecin3riskorcin3riskmeasuresreliablesurrogatesforinvasivecervicalcancerrisk

Ejemplares similares